Kalyan C Mantripragada - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Future Oncology (London, England)|March 5, 2016

Optimizing initial chemotherapy for metastatic pancreatic cancerKalyan C Mantripragada, Howard Safran

Journal of the National Comprehensive Cancer Network : JNCCN|September 3, 2016

Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell LymphomaAdam J Olszewski, Kalyan C Mantripragada, Jorge J Castillo

Journal of the National Cancer Institute|October 7, 2016

Adjuvant Therapy for Resected Gallbladder Cancer: Analysis of the National Cancer Data BaseKalyan C Mantripragada, Fatima Hamid, Hammad Shafqat, et al.

Journal of Oncology Practice|February 25, 2016

Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer ProgramKalyan C Mantripragada, Adam J Olszewski, Andrew Schumacher, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Future Oncology (London, England)|March 5, 2016

Optimizing initial chemotherapy for metastatic pancreatic cancerKalyan C Mantripragada, Howard Safran

Journal of the National Comprehensive Cancer Network : JNCCN|September 3, 2016

Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell LymphomaAdam J Olszewski, Kalyan C Mantripragada, Jorge J Castillo

Journal of the National Cancer Institute|October 7, 2016

Adjuvant Therapy for Resected Gallbladder Cancer: Analysis of the National Cancer Data BaseKalyan C Mantripragada, Fatima Hamid, Hammad Shafqat, et al.

Journal of Oncology Practice|February 25, 2016

Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer ProgramKalyan C Mantripragada, Adam J Olszewski, Andrew Schumacher, et al.

Pageof 1